Onderneming Arcturus Therapeutics Holdings Inc.
Aandelen
ARCT
US03969T1097
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
26,32 USD | -4,78% | -19,11% | -16,52% |
Vakgebied
Aantal werknemers: 180
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Nucleic Acid-focused Technology
100,0
%
| 206 | 100,0 % | 167 | 100,0 % | -19,03% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 206 | 100,0 % | 167 | 100,0 % | -19,03% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Payne
CEO | Chief Executive Officer | 52 | 01-03-13 |
Andrew Sassine
DFI | Director of Finance/CFO | 59 | 01-09-19 |
Chief Operating Officer | 45 | 01-01-13 | |
Chief Tech/Sci/R&D Officer | 68 | 01-03-23 | |
Neda Safarzadeh
IRC | Investor Relations Contact | - | - |
Lance Kurata
LAW | General Counsel | 54 | 10-08-20 |
Kevin T. Skol
PRN | Corporate Officer/Principal | - | 01-01-02 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Edward W. Holmes
BRD | Director/Board Member | 83 | 01-09-19 |
James F. Barlow
BRD | Director/Board Member | 65 | 27-05-18 |
Peter Farrell
CHM | Chairman | 81 | 27-05-18 |
Andrew Sassine
DFI | Director of Finance/CFO | 59 | 01-09-19 |
Magda Marquet
BRD | Director/Board Member | 65 | 27-05-18 |
Jing Marantz
BRD | Director/Board Member | 59 | 07-12-21 |
Joseph Payne
CEO | Chief Executive Officer | 52 | 01-03-13 |
John Markels
BRD | Director/Board Member | 58 | 08-12-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 26 915 243 | 24 560 665 ( 91,25 %) | 0 | 91,25 % |
Bedrijfsgegevens
Arcturus Therapeutics Holdings, Inc.
10628 Science Center Drive Suite 250
92121, San Diego
+
http://www.arcturusrx.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-16,52% | 708 mln. | |
-1,82% | 41,35 mld. | |
+42,55% | 40,38 mld. | |
+2,56% | 39,05 mld. | |
-12,11% | 26,67 mld. | |
+3,09% | 24,07 mld. | |
-24,16% | 18,36 mld. | |
+22,12% | 11,6 mld. | |
-3,74% | 11,68 mld. | |
+7,75% | 11,15 mld. |
- Beurs
- Aandelen
- Koers ARCT
- Onderneming Arcturus Therapeutics Holdings Inc.